Loading clinical trials...
Loading clinical trials...
The investigators propose the evaluation of posaconazole and benznidazole in humans for the treatment of Chagas disease chronical infection. Exploratory trial of posaconazole antiparasitic activity ag...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Collaborators
NCT06632600 · Chagas Disease
NCT04984265 · Ventricular Tachycardia, Chagas Disease, and more
NCT02625974 · Chagas Disease
NCT03981523 · Trypanosoma Cruzi Infection, Chagas Disease
NCT00123916 · Chagas Disease, Trypanosomiasis, and more
International Health Unit Metropolitana Nord
Santa Coloma, Barcelona
Infectious Disease Department Vall d'Hebron Hospital
Barcelona
International Health Unit Drassanes
Barcelona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions